Encepheal Therapeutics

Winston-Salem, US · Founded 2015 · 3 employees · Inactive · 1 known investors

EncepHeal develops small-molecule medications targeting the dopamine transporter to treat stimulant addiction, including cocaine and methamphetamine, for which no FDA-approved treatments currently exist. The company uses allosteric modulators designed to reduce drug cravings without the addictive potential of earlier dopamine-targeting approaches.